Blended Learning Journey Thyroid Disorders 2024

from 31 May to 22 November 2024


Blended Learning Journey on Thyroid Disorders 2024

from 31 May to 22 November 2024


Thyroid biomarker testing is the cornerstone of diagnosis, but is beset by issues of reproducibility between laboratories, within laboratories and even between samples from the same patient taken at different times of the day. Patients experience transient changes in thyroid parameters, and levels are impacted by age and ethnicity (Jonklaas, 2019), all of which need to be accounted for in deciding whether a patient has thyroid dysfunction. Early accurate diagnosis of thyroid problems is a real issue for patient quality of life and in preventing secondary health problems. Related to this subject is the need for awareness of the way that thyroid biomarkers, particularly thyroid stimulating hormone (TSH), change as a patient ages, to avoid over treatment of older adults. Ethnicity and weight are also key issues for assessment of TSH levels. Pregnancy and hypothyroidism remain an area of educational need, as does long-term monitoring for women who develop post-partum hypothyroidism following hypothyroidism pre- or during pregnancy. The unregulated and open nature of health information on the internet and social media can lead to patient misinformation. The ability to discuss contentious and misleading information with patients is a skill in increasing demand in the healthcare community.

Learning Objectives

At the end of the blended learning journey, participants will be able to:

Target Audience

Clinicians involved in endocrinology, particularly thyroid disorders and general practice; some content of interest to pediatricians, biochemists, clinical and research scientists, and those involved in pre-natal, pregnancy and post-natal care.


The official language of this educational programme will be English. Simultaneous translation into Spanish and Chinese will be provided.

Continuing Medical Education

The BLENDED LEARNING JOURNEY ON THYROID DISORDERS 2024 will be submitted for CME accreditation from the European Accreditation Council for Continuing Medical Education (EACCME), and/ or the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) and for Continuing Professional Development (CPD) credits.

E-learning Modules

E-learning Modules

This learning journey is a structured educational programme comprising:

Save the Date

Download STD